Co-cultivation of murine BMDCs with 67NR mouse mammary carcinoma cells give rise to highly drug resistant cells

Cancer Cell International

Volumn 11, Issue , 2011, Pages

  Nagler, Christa ^a   Hardt, Cornelia ^b   Zänker, Kurt S ^a   Dittmar, Thomas ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALVESPIMYCIN; DOXORUBICIN; ETOPOSIDE; GLYCOPROTEIN P; HYGROMYCIN; PACLITAXEL; PUROMYCIN; RHODAMINE 123; VERAPAMIL;

ABCB1A GENE; ABCB1B GENE; ALLELE; ANIMAL CELL; ARTICLE; BONE MARROW CELL; BREAST CARCINOMA; CARCINOMA CELL; CELL CLONE; CELL FUSION; COCULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG RESISTANCE; GENE; GENE EXPRESSION; HORIZONTAL GENE TRANSFER; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; SHORT TANDEM REPEAT; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING;

EID: 79959613246     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-11-21     Document Type: Article

References (49)

1. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?. Lancet 2001, 357(9255):539-545. 10.1016/S0140-6736(00)04046-0, 11229684.
2. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986, 315(26):1650-1659. 10.1056/NEJM198612253152606, 3537791.
3. Dittmar T, Seidel J, Zänker KS, Niggemann B. Carcinogenesis driven by bone marrow-derived stem cells. Contrib Microbiol 2006, 13:156-169.
4. Rizvi AZ, Swain JR, Davies PS, Bailey AS, Decker AD, Willenbring H, Grompe M, Fleming WH, Wong MH. Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc Natl Acad Sci USA 2006, 103(16):6321-6325. 10.1073/pnas.0508593103, 1435365, 16606845.
5. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR, Wang TC. Gastric cancer originating from bone marrow-derived cells. Science 2004, 306(5701):1568-1571. 10.1126/science.1099513, 15567866.
6. Hall B, Dembinski J, Sasser AK, Studeny M, Andreeff M, Marini F. Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Int J Hematol 2007, 86(1):8-16. 10.1532/IJH97.06230, 17675260.
7. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449(7162):557-563. 10.1038/nature06188, 17914389.
8. Zhu W, Xu W, Jiang R, Qian H, Chen M, Hu J, Cao W, Han C, Chen Y. Mesenchymal stem cells derived from bone marrow favor tumor cell growth in vivo. Exp Mol Pathol 2006, 80(3):267-274. 10.1016/j.yexmp.2005.07.004, 16214129.
9. Samudio I, Fiegl M, McQueen T, Clise-Dwyer K, Andreeff M. The warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activation. Cancer Res 2008, 68(13):5198-5205. 10.1158/0008-5472.CAN-08-0555, 2562568, 18593920.
10. Tabe Y, Jin L, Tsutsumi-Ishii Y, Xu Y, McQueen T, Priebe W, Mills GB, Ohsaka A, Nagaoka I, Andreeff M, et al. Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells. Cancer Res 2007, 67(2):684-694. 10.1158/0008-5472.CAN-06-3166, 17234779.
11. Powell AE, Anderson EC, Davies PS, Silk AD, Pelz C, Impey S, Wong MH. Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming. Cancer Res 2011, 71(4):1497-1505. 10.1158/0008-5472.CAN-10-3223, 21303980.
12. Duelli D, Lazebnik Y. Cell fusion: a hidden enemy?. Cancer Cell 2003, 3(5):445-448. 10.1016/S1535-6108(03)00114-4, 12781362.
13. Lu X, Kang Y. Cell fusion as a hidden force in tumor progression. Cancer Res 2009, 69(22):8536-8539. 10.1158/0008-5472.CAN-09-2159, 2783941, 19887616.
14. Mekler LB. [Hybridization of transformed cells with lymphocytes as 1 of the probable causes of the progression leading to the development of metastatic malignant cells]. Vestnik Akademii meditsinskikh nauk SSSR 1971, 26(8):80-89.
15. Mekler LB, Drize OB, Osechinskii IV, Shliankevich MA. [Transformation of a normal differentiated cell of an adult organism, induced by the fusion of this cell with another normal cell of the same organism but with different organ or tissue specificity]. Vestnik Akademii meditsinskikh nauk SSSR 1971, 26(4):75-80.
16. Dittmar T, Schwitalla S, Seidel J, Haverkampf S, Reith G, Meyer-Staeckling S, Brandt BH, Niggemann B, Zanker KS. Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells. Clin Exp Metastasis 2011, 28(1):75-90. 10.1007/s10585-010-9359-3, 20981475.
17. Lu X, Kang Y. Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Proc Natl Acad Sci USA 2009, 106(23):9385-9390. 10.1073/pnas.0900108106, 2695061, 19458257.
18. Duelli DM, Lazebnik YA. Primary cells suppress oncogene-dependent apoptosis. Nat Cell Biol 2000, 2(11):859-862. 10.1038/35041112, 11056544.
19. Bjerkvig R, Tysnes BB, Aboody KS, Najbauer J, Terzis AJ. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 2005, 5(11):899-904. 10.1038/nrc1740, 16327766.
20. Dittmar T, Nagler C, Schwitalla S, Reith G, Niggemann B, Zanker KS. Recurrence cancer stem cells--made by cell fusion?. Med Hypotheses 2009, 73(4):542-547. 10.1016/j.mehy.2009.05.044, 19564079.
21. Chakraborty AK, Sodi S, Rachkovsky M, Kolesnikova N, Platt JT, Bolognia JL, Pawelek JM. A spontaneous murine melanoma lung metastasis comprised of host x tumor hybrids. Cancer Res 2000, 60(9):2512-2519.
22. Rachkovsky M, Sodi S, Chakraborty A, Avissar Y, Bolognia J, McNiff JM, Platt J, Bermudes D, Pawelek J. Melanoma x macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis 1998, 16(4):299-312.
23. Pawelek J, Chakraborty A, Lazova R, Yilmaz Y, Cooper D, Brash D, Handerson T. Co-opting macrophage traits in cancer progression: a consequence of tumor cell fusion?. Contrib Microbiol 2006, 13:138-155.
24. Pawelek JM, Chakraborty AK. Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer 2008, 8(5):377-386. 10.1038/nrc2371, 18385683.
25. Bjerregaard B, Holck S, Christensen IJ, Larsson LI. Syncytin is involved in breast cancer-endothelial cell fusions. Cell Mol Life Sci 2006, 63(16):1906-1911. 10.1007/s00018-006-6201-9, 16871371.
26. Shabo I, Stal O, Olsson H, Dore S, Svanvik J. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int J Cancer 2008, 123(4):780-786. 10.1002/ijc.23527, 18506688.
27. Shabo I, Olsson H, Sun XF, Svanvik J. Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. Int J Cancer 2009, 125(8):1826-1831. 10.1002/ijc.24506, 19582880.
28. Andersen TL, Boissy P, Sondergaard TE, Kupisiewicz K, Plesner T, Rasmussen T, Haaber J, Kolvraa S, Delaisse JM. Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone: a new type of cancer-host partnership?. J Pathol 2007, 211(1):10-17. 10.1002/path.2078, 17083146.
29. Silvestris F, Ciavarella S, Strippoli S, Dammacco F. Cell fusion and hyperactive osteoclastogenesis in multiple myeloma. Adv Exp Med Biol 2011, 714:113-128.
30. Larsson LI, Holck S, Christensen IJ. Prognostic role of syncytin expression in breast cancer. Hum Pathol 2007, 38(5):726-731. 10.1016/j.humpath.2006.10.018, 17306327.
31. Sinkovics JG. Horizontal Gene Transfers with or without Cell Fusions in All Categories of the Living Matter. Adv Exp Med Biol 2011, 714:5-89.
32. Holmgren L. Horizontal gene transfer: you are what you eat. Biochem Biophys Res Commun 2010, 396(1):147-151. 10.1016/j.bbrc.2010.04.026, 20494129.
33. Ehnfors J, Kost-Alimova M, Persson NL, Bergsmedh A, Castro J, Levchenko-Tegnebratt T, Yang L, Panaretakis T, Holmgren L. Horizontal transfer of tumor DNA to endothelial cells in vivo. Cell Death Differ 2009, 16(5):749-757. 10.1038/cdd.2009.7, 19219067.
34. Tome Y, Tsuchiya H, Hayashi K, Yamauchi K, Sugimoto N, Kanaya F, Tomita K, Hoffman RM. In vivo gene transfer between interacting human osteosarcoma cell lines is associated with acquisition of enhanced metastatic potential. J Cell Biochem 2009, 108(2):362-367. 10.1002/jcb.22259, 19623575.
35. Hadjantonakis AK, Gertsenstein M, Ikawa M, Okabe M, Nagy A. Generating green fluorescent mice by germline transmission of green fluorescent ES cells. Mech Dev 1998, 76(1-2):79-90. 10.1016/S0925-4773(98)00093-8, 9867352.
36. Dexter DL, Kowalski HM, Blazar BA, Fligiel Z, Vogel R, Heppner GH. Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 1978, 38(10):3174-3181.
37. Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992, 52(6):1399-1405.
38. Ying QL, Nichols J, Evans EP, Smith AG. Changing potency by spontaneous fusion. Nature 2002, 416(6880):545-548. 10.1038/nature729, 11932748.
39. Dittmar T, Heyder C, Gloria-Maercker E, Hatzmann W, Zanker KS. Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner. Clin Exp Metastasis 2008, 25(1):11-32. 10.1007/s10585-007-9095-5, 18563596.
40. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002, 420(6917):860-867. 10.1038/nature01322, 2803035, 12490959.
41. Terada N, Hamazaki T, Oka M, Hoki M, Mastalerz DM, Nakano Y, Meyer EM, Morel L, Petersen BE, Scott EW. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002, 416(6880):542-545. 10.1038/nature730, 11932747.
42. Li R, Sonik A, Stindl R, Rasnick D, Duesberg P. Aneuploidy versus gene mutation hypothesis of cancer: recent study claims mutation, but is found to support aneuploidy. Proc Natl Acad Sci USA 2000, 97:3236-3241. 10.1073/pnas.040529797, 16222, 10725343.
43. Duncan AW, Hickey RD, Paulk NK, Culberson AJ, Olson SB, Finegold MJ, Grompe M. Ploidy reductions in murine fusion-derived hepatocytes. PLoS genetics 2009, 5(2):e1000385. 10.1371/journal.pgen.1000385, 2636893, 19229314.
44. Duncan AW, Taylor MH, Hickey RD, Hanlon AE, Lenzi ML, Olson SB, Finegold MJ, Grompe M. The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature 2010, 467(7316):707-710. 10.1038/nature09414, 2967727, 20861837.
45. Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 2006, 5(3):219-234. 10.1038/nrd1984, 16518375.
46. Lagas JS, Fan L, Wagenaar E, Vlaming ML, van Tellingen O, Beijnen JH, Schinkel AH. P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 determine the pharmacokinetics of etoposide. Clin Cancer Res 2010, 16(1):130-140. 10.1158/1078-0432.CCR-09-1321, 20028753.
47. Lagas JS, Vlaming ML, Schinkel AH. Pharmacokinetic assessment of multiple ATP-binding cassette transporters: the power of combination knockout mice. Mol Interv 2009, 9(3):136-145. 10.1124/mi.9.3.7, 19592674.
48. Allen JD, Van Dort SC, Buitelaar M, van Tellingen O, Schinkel AH. Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein. Cancer Res 2003, 63(6):1339-1344.
49. Dittmar T, Schafer F, Brandt BH, Zänker KS. Accelerated assessing of antisense RNA efficacy using a chimeric enhanced green fluorescent protein-antisense RNA-producing vector. Antisense Nucleic Acid Drug Dev 2000, 10(5):401-408. 10.1089/oli.1.2000.10.401, 11079579.